Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPV7 Vaccine + TLR Agonists in Resected Melanoma
NCT02126579Phase 2Completed
- Start
- May 2014
- Primary completion
- Nov 2019
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of LPV7 in melanoma. Started May 2014; status: completed.
02
Drugs
LPV7
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02126579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02126579.